Extracellular Matrix News Volume 3.15 | Apr 19 2012

    0
    21

    Extracellular Matrix News 3.15, April 19, 2012
         In this issue: Publications | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Extracellular Matrix News on Twitter

    TOP STORY
    Enhancing the Biological Performance of Synthetic Polymeric Materials by Decoration with Engineered, Decellularized Extracellular Matrix
    Scientists tested the hypothesis that the biological performance of three-dimensional synthetic polymer-based scaffolds can be enhanced by extracellular matrix deposited by cells in vitro and subsequently decellularized. [Biomaterials] Abstract

    View Lectures, Tools, Protocols and Other Resources on the Human Immunology Portal

    PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Interplay of Cell Adhesion Matrix Stiffness and Cell Type for Non-Viral Gene Delivery
    Scientists report that the effect of matrix stiffness on non-viral gene delivery differs among cell types due to varying sensitivities to matrix rigidity. [Acta Biomater] Abstract

    NEDD9 Stabilizes Focal Adhesions, Increases Binding to the Extracellular Matrix and Differentially Effects Two-Dimensional versus Three-Dimensional Cell Migration
    Researchers’ data suggests that NEDD9 may promote three-dimensional cell migration by slowing focal adhesion disassembly, promoting integrin receptor activation and increasing adhesion force to the extracellular matrix. [PLoS One] Abstract

    Cell Therapy Limits Myofibroblast Differentiation and Structural Cardiac Remodeling: bFGF-Mediated Paracrine Mechanism
    The effect of cell therapy on post-infarction cardiac fibroblast and extracellular matrix regulation was examined. [Circ Heart Fail] Abstract

    Specificity of Latent TGF-ß Binding Protein (LTBP) Incorporation into Matrix: Role of Fibrillins and Ribronectin
    Scientists analyzed both in vitro and in vivo the role of fibrillin microfibrils in the matrix deposition of LTBP-1, -3 and -4. [J Cell Physiol] Abstract

    Glycosaminoglycans Enhance Osteoblast Differentiation of Bone Marrow Derived Human Mesenchymal Stem Cells
    Investigators confirmed and emphasized the significant role of extracellular matrix in regulating cell differentiation. [J Tissue Eng Regen Med] Abstract

    Glycosaminoglycan Backbone Is Not Required for the Modulation of Hemostasis: Effect of Different Heparin Derivatives and Non-Glycosaminoglycan Analogs
    Researchers examined a variety of heparinomimetics biochemically and pharmacologically, as well as their interactions with cells from the vessel wall using a time resolved fluorometric method and confocal microscopy. [Matrix Biol] Abstract

    Endoplasmic Reticulum Stress Modulates Nicotine-Induced Extracellular Matrix Degradation in Human Periodontal Ligament Cells
    Investigators examined whether endoplasmic reticulum stress was responsible for nicotine-induced cytotoxicity and extracellular matrix degradation. [J Periodontal Res] Abstract

    Do Your Colleagues Know What They Are Missing? Share This Newsletter Now.

    INDUSTRY NEWS

    Baxter and Halozyme Provide Update on HyQ Biologics License Application
    Baxter International Inc. and Halozyme Therapeutics, Inc. announced that the U.S. Food and Drug Administration is requesting additional information to complete its review of the HyQ Biologics License Application. [Halozyme Therapeutics, Inc.] Press Release

    Piramal Healthcare Announces Approval of Its First Innovative Product for Regenerative Medicine, BST-CarGel®
    Piramal Healthcare Limited announced that it has received the European CE mark approval for its innovative bio-orthopedic product for cartilage repair, BST-CarGel®. [Piramal Healthcare Limited] Press Release

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)
     
    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS

    NEW Federation of American Societies for Experimental Biology (FASEB) – Smooth Muscle Conference
    June 24-29, 2012
    Snowmass Village, United States

    Visit our events page to see a complete list of events in the extracellular matrix community.

    JOB OPPORTUNITIES
    Scientist – Endothelial Cells (STEMCELL Technologies, Inc.)

    Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.)

    Scientist – Hematology (STEMCELL Technologies, Inc.)

    Scientist – hPSC (STEMCELL Technologies, Inc.)

    Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.)

    Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.)

    Scientist – Antibody and Hybridoma Technology Platforms (STEMCELL Technologies, Inc.)

    Business Analyst – Product Management (STEMSOFT Software, Inc.)

    Postgraduate Position – Cutaneous Biology (Northwestern University) 

    PhD Student – Extracellular Matrix Proteins/Stem Cell Biology (Cardiff University, School of Dentistry)

    PhD Student – Extracellular Vesicles, Isolation, Detection and Characterization (Lab Semmelweis University)


    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Jobs are categorized regionally: United States, Canada, Europe, Middle East to Asia Pacific

    Visit here to post your career opportunities.

    Have we missed an important article or publication in Extracellular Matrix News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Extracellular Matrix Cell News: Archives | Events | Contact Us